Vivo Bio Tech Quarterly Results

Charts

YoY Net Sales (Quarterly)

Operating Margin

EPS Growth

POSITIVES

Revenue shows an upward trend with a peak in 202312 and 202409, indicating strong demand.
Net profit surged to 5.23 crore in 202409, reflecting improved efficiency and cost management.
Operating profit margins have remained relatively stable, indicating good operational control amidst fluctuating revenues.

NEGATIVES

Revenue declined significantly in 202309, showing vulnerability to market fluctuations.
Profit before tax dropped in 202403, highlighting potential cost challenges during that period.
The tax rate spiked in 202403, impacting net profit, indicating possible regulatory changes affecting profitability.

Field	Mar 23	Jun 23	Sep 23	Dec 23	Mar 24	Jun 24	Sep 24	Dec 24	Mar 25	Jun 25
Revenue	14.76	11.58	9.26	12.85	11.76	10.13	12.04	12.21	12.29	12.51
Expenses	7.63	7.10	4.40	6.47	6.39	5.77	6.44	6.67	7.28	7.02
Operating Profit	7.13	4.48	4.86	6.38	5.37	4.36	5.59	5.54	5.02	5.49
Other Income	0.02	0	0	0.03	0.01	0.01	4.63	0.01	0.15	0.14
Interest	2.01	1.95	2.09	2.22	1.52	1.92	2.06	1.84	1.68	1.50
Depreciation	2.26	2.29	2.30	2.28	2.43	2.23	2.29	2.25	2.25	2.64
Profit Before Tax	2.88	0.25	0.46	1.91	1.43	0.22	5.87	1.46	1.24	1.48
Tax	0.81	0.11	0.14	0.59	0.70	0.06	0.63	0.64	0.18	0.14
Net Profit	2.06	0.14	0.33	1.32	0.74	0.17	5.23	0.82	1.06	1.34
Eps in Rs	1.38	0.10	0.22	0.89	0.50	0.11	3.51	0.55	0.69	0.74